Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use

Background. The main purpose of the Her2/neu status determination in clinical practice is to determine the indications for the appointment of targeted therapy. The main methods for detecting the Her2/neu status are the immunohistochemical method (IHC) and the fluorescence in situ hybridization (FISH...

Full description

Saved in:
Bibliographic Details
Main Authors: O. D. Bragina, V. I. Chernov, E. Yu. Garbukov, A. V. Doroshenko, A. G. Vorobyeva, A. M. Orlova, V. M. Tolmachev
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2021-04-01
Series:Бюллетень сибирской медицины
Subjects:
lternative scaffold proteins
radionuclide diagnostics
her2/neu
breast cancer
targeted therapy
Online Access:https://bulletin.ssmu.ru/jour/article/view/4270
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bulletin.ssmu.ru/jour/article/view/4270

Similar Items